Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01623856 · ClinicalTrials.gov registry record
Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 483
- Enrollment target
NCT01623856 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 483 participants.
The verdict
NCT01623856 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 483 participants
- Enrollment target
Study Summary
This research studies genes associated with non-Hodgkin lymphoma in young patients. Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 483 participants |
| Start Date | 2012-06 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01623856
The ClinicalTrials.gov registry entry for NCT01623856 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 483 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01623856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01623856 about?
NCT01623856 is a clinical study titled "Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients". This research studies genes associated with non-Hodgkin lymphoma in young patients. Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
What is the current status of trial NCT01623856?
This trial is currently completed. The enrollment target is 483 participants. The study started on 2012-06. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01623856?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01623856?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.